Jan 29 (Reuters) - Alder Biopharmaceuticals Inc:
* ALDER BIOPHARMACEUTICALS, INC. ANNOUNCES OFFERING OF $200 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2025
* ALDER BIOPHARMACEUTICALS - INTENDS TO USE PROCEEDS FROM OFFERING TO FUND DEVELOPMENT, COMMERCIALIZATION OF EPTINEZUMAB Source text for Eikon: Further company coverage:
 